In contrast to a previous report showing unaltered LDL-C levels in MS [27], we found decreased LDL-C, LDL-FC, LDL-PL, and LDL-apoB levels in MS patients, probably due to statin use in 35.4% of these patients. The gene discussed is APOB; the disease is myeloid sarcoma.